Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StaphVAX in adults on hemodialysis
NCT00071214Phase 3Completed
- Sponsor
- Nabi Biopharmaceuticals
- Start
- Sep 2003
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 3, randomised, double-blind trial of s. aureus type 5 & 8 capsular polysaccharide vaccine in Staphylococcus aureus infection, sponsored by Nabi Biopharmaceuticals. Primary endpoint: Documented S. aureus invasive infection. Started Sep 2003; status: completed.
02
Drugs
s. aureus type 5 & 8 capsular polysaccharide vaccine
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT00071214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00071214.